BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sambamoorthy U, Manjappa AS, Eswara BRM, Sanapala AK, Nagadeepthi N. Vitamin E Oil Incorporated Liposomal Melphalan and Simvastatin: Approach to Obtain Improved Physicochemical Characteristics of Hydrolysable Melphalan and Anticancer Activity in Combination with Simvastatin Against Multiple Myeloma. AAPS PharmSciTech 2021;23:23. [PMID: 34907484 DOI: 10.1208/s12249-021-02177-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin Z, Chu B, Qu Y, Wei X, Huang J, Wang F, Feng Y, Wang X, Luo H, Zhai X, Xu J, Liu X, Zhang L, Chen F, Wu Y, Zheng Y. Liposome-Encapsulated Melphalan Exhibits Potent Antimyeloma Activity and Reduced Toxicity. ACS Omega 2023;8:1693-701. [PMID: 36643473 DOI: 10.1021/acsomega.2c07555] [Reference Citation Analysis]
2 Patil SS, Chougale RD, Manjappa AS, Disouza JI, Hajare AA, Patil KS. Statistically developed docetaxel-laden mixed micelles for improved therapy of breast cancer. OpenNano 2022;8:100079. [DOI: 10.1016/j.onano.2022.100079] [Reference Citation Analysis]
3 Kumbhar P, Khade V, Khadake V, Marale P, Manjappa A, Nadaf S, Kumbar V, Bhagwat D, Disouza J. Ifosfamide-Loaded Cubosomes: An Approach to Potentiate Cytotoxicity against MDA-MB-231 Breast Cancer Cells. Fabad J Pharm Sci 2022. [DOI: 10.55262/fabadeczacilik.1145208] [Reference Citation Analysis]
4 Patil KS, Hajare AA, Manjappa AS, More HN, Disouza JI. Design, Development, In Silico, and In Vitro Characterization of Camptothecin-Loaded Mixed Micelles: In Vitro Testing of Verapamil and Ranolazine for Repurposing as Coadjuvant Therapy in Cancer. J Pharm Innov. [DOI: 10.1007/s12247-022-09688-0] [Reference Citation Analysis]
5 Unnam S, Manjappa AS, Muddana Eswara BR, Salawi A, Gunti P. Liposomal Melphalan: Approach to obtain improved plasma stability, pharmacokinetics, and in vitro and in vivo anticancer efficacy in combination with liposomal simvastatin against mouse RPMI-8226 multiple myeloma model. Journal of Drug Delivery Science and Technology 2022;73:103479. [DOI: 10.1016/j.jddst.2022.103479] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Negrea G, Rauca VF, Meszaros MS, Patras L, Luput L, Licarete E, Toma VA, Porfire A, Muntean D, Sesarman A, Banciu M. Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis. Front Pharmacol 2022;13:870347. [PMID: 35450036 DOI: 10.3389/fphar.2022.870347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]